Achim Kaufhold
Hoofd Techniek/Wetenschap/O&O bij HANSA BIOPHARMA AB
Profiel
Achim Kaufhold is currently the Director at Anzamune Ltd.
since 2007, Professor at RWTH Aachen University since 1993, and Chief Medical Officer & Senior Vice President at Hansa Biopharma AB since 2020.
Previously, he served as the President & Chief Executive Officer at Affitech A from 2008 to 2009, Chairman at CMP Therapeutics Ltd., Director-Clinical Development at GSK Plc, Director-Executive Board at Pevion Biotech AG from 2009 to 2010, Independent Director at Vaximm AG, Independent Director at Biosergen AB from 2021 to 2024, Chief Medical Officer & Vice President at Chiron Corp.
from 2005 to 2006, Chief Medical Officer at Berna Biotech AG from 2001 to 2005, Chief Scientific & Medical Officer at Pharmexa A from 2007 to 2009, and Chief Medical Officer at Basilea Pharmaceutica AG from 2010 to 2017.
He holds a doctorate degree from Universität zu Köln.
Actieve functies van Achim Kaufhold
| Bedrijven | Functie | Begin |
|---|---|---|
| HANSA BIOPHARMA AB | Hoofd Techniek/Wetenschap/O&O | 01-06-2020 |
| RWTH Aachen University | Corporate Officer/Principal | 29-12-2009 |
Anzamune Ltd.
 Anzamune Ltd. Pharmaceuticals: MajorHealth Technology Anzamune Ltd. develops therapeutic drugs. It also develops drugs for allergic disorders. Its products are based on chitin, a natural product found widely in shellfish and insect shells. The company was founded on June 6, 2007 and is headquartered in Ashhurst, New Zealand. | Directeur/Bestuurslid | 07-08-2007 |
Eerdere bekende functies van Achim Kaufhold
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOSERGEN AB | Directeur/Bestuurslid | 14-06-2024 |
| BASILEA PHARMACEUTICA AG | Hoofd Techniek/Wetenschap/O&O | 01-12-2017 |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Directeur/Bestuurslid | 01-02-2016 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Algemeen Directeur | 16-06-2009 |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Algemeen Directeur | 01-01-2009 |
Opleiding van Achim Kaufhold
| Universität zu Köln | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| GSK PLC | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| BIOSERGEN AB | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
Pevion Biotech AG
 Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Pevion Biotech AG develops efficient and safe vaccines based on proprietary technology. The firm provides preclinical and clinical development of prophylactic/therapeutic vaccines based on its virosome-based technology platform. The company was founded in 2002 and is headquartered in Ittigen, Switzerland. | Health Technology |
Anzamune Ltd.
Anzamune Ltd. Pharmaceuticals: MajorHealth Technology Anzamune Ltd. develops therapeutic drugs. It also develops drugs for allergic disorders. Its products are based on chitin, a natural product found widely in shellfish and insect shells. The company was founded on June 6, 2007 and is headquartered in Ashhurst, New Zealand. | Health Technology |
CMP Therapeutics Ltd.
 CMP Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology CMP Therapeutics Ltd. developed products for colds, flu, and allergy. It offered nasal spray for allergic rhinitis; and anti-infective nasal spray for preventing influenza and colds. The company was founded in 2004 and was headquartered in Oxford, the United Kingdom. | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
